The OECD.AI Policy Navigator

Our policy navigator is a living repository from more than 80 jurisdictions and organisations. Use the filters to browse initiatives and find what you are looking for.

Centers of Excellence in Regulatory Science and Innovation


Added by:   National contact point
Added on:   09 Jul 2025
Updated by:   OECD analyst
Updated on:   25 Dec 2025

The Food and Drug Administration's(FDA) Centers of Excellence in Regulatory Science and Innovation (CERSIs) are collaborations between FDA and academic institutions to advance regulatory science through innovative research, training, and scientific exchanges.

Name in original language

Centers of Excellence in Regulatory Science and Innovation

Initiative overview

The initiative has the following objective(s):To develop the tools, standards, and approaches required to assess the safety, efficacy, quality, and performance of innovative products.To harness these newly developed tools, standards, and approaches in collaboration with academia, industry, and other governmental agencies.

Name of responsible organisation (in English)

Food and Drug Administration (FDA)

About the policy initiative


Organisation:

  • Food and Drug Administration (FDA)

Category:

  • AI policy initiatives, programmes and projects

Initiative type:

  • AI Research Centres/Centres of Excellence/Expertise, specialised AI teams, labs

Status:

  • Active

Start Year:

  • 2013

Binding:

  • Non-binding

Other relevant urls: